Burcon Current Deferred Revenue from 2010 to 2026
| BU Stock | CAD 1.94 0.04 2.02% |
Current Deferred Revenue | First Reported 2011-06-30 | Previous Quarter -46.1 K | Current Value -36.9 K | Quarterly Volatility 312.7 K |
Check Burcon NutraScience financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Burcon NutraScience's main balance sheet or income statement drivers, such as Interest Expense of 807.5 K, Other Operating Expenses of 5.5 M or Total Operating Expenses of 5.4 M, as well as many indicators such as Price To Sales Ratio of 42.56, Dividend Yield of 0.0 or PTB Ratio of 2.34. Burcon financial statements analysis is a perfect complement when working with Burcon NutraScience Valuation or Volatility modules.
Burcon | Current Deferred Revenue |
Evaluating Burcon NutraScience's Current Deferred Revenue across multiple reporting periods reveals the company's ability to sustain growth and manage resources effectively. This longitudinal analysis highlights inflection points, cyclical patterns, and structural changes that short-term snapshots might miss, offering deeper insight into Burcon NutraScience's fundamental strength.
Latest Burcon NutraScience's Current Deferred Revenue Growth Pattern
Below is the plot of the Current Deferred Revenue of Burcon NutraScience over the last few years. It is revenue that has been collected but not yet earned, typically from prepaid service contracts or subscriptions. This amount is considered a liability until the service is provided or the subscription period ends. Burcon NutraScience's Current Deferred Revenue historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Burcon NutraScience's overall financial position and show how it may be relating to other accounts over time.
| Current Deferred Revenue | 10 Years Trend |
|
Current Deferred Revenue |
| Timeline |
Burcon Current Deferred Revenue Regression Statistics
| Arithmetic Mean | 211,029 | |
| Geometric Mean | 135,756 | |
| Coefficient Of Variation | 111.43 | |
| Mean Deviation | 191,294 | |
| Median | 222,656 | |
| Standard Deviation | 235,153 | |
| Sample Variance | 55.3B | |
| Range | 598.9K | |
| R-Value | (0.56) | |
| Mean Square Error | 40.3B | |
| R-Squared | 0.32 | |
| Significance | 0.02 | |
| Slope | (26,234) | |
| Total Sum of Squares | 884.8B |
Burcon Current Deferred Revenue History
About Burcon NutraScience Financial Statements
Burcon NutraScience investors utilize fundamental indicators, such as Current Deferred Revenue, to predict how Burcon Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
| Last Reported | Projected for Next Year | ||
| Current Deferred Revenue | -31.2 K | -29.7 K |
Other Information on Investing in Burcon Stock
Burcon NutraScience financial ratios help investors to determine whether Burcon Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Burcon with respect to the benefits of owning Burcon NutraScience security.